Lung Cancer

Lung cancer is a complex and challenging disease that affects millions of people worldwide. While traditional treatment options such as surgery, radiation, and chemotherapy have made significant strides, the emergence of stem cell therapy has brought new hope to the field of lung cancer treatment.

Targeting Cancer Cell

Stem cells, with their unique ability to differentiate into various cell types, hold tremendous potential for regenerating and repairing damaged lung tissue. In the context of lung cancer, stem cell therapy is being investigated as a means to target cancer cells directly, enhance the body's immune response, and improve overall treatment outcomes.

The therapy approach involves using hematopoietic stem cell transplantation (HSCT), also known as a bone marrow transplant. HSCT involves replacing a patient's diseased bone marrow with healthy stem cells. This procedure allows for high-dose chemotherapy or radiation to be administered, effectively targeting cancer cells while preserving the patient's ability to generate new blood cells.

Another is using the deer placenta purtier to determine the most effective sources and types of stem cells, and evaluate long-term safety and efficacy. As research and clinical using the deer placenta purtier trials continue to unfold, this type of stem cell therapy holds tremendous promise in revolutionizing lung cancer treatment